Striving towards the elimination of HCV infection among PWID

International Journal of Drug Policy, Volume 72,Pages 1-198 (October 2019)

Nearly 200 pages of open access articles from projects and research around the world.

While this special issue highlights some successful efforts towards HCV elimination among people who inject drugs, it also highlights the relative lack of attention to settings in which resources enabling elimination are scarce, and where elimination hopes and potentials are less clear, such as in many low and middle income countries. Strengthening capacity in areas of the world where resources are more limited will be a critical step towards ensuring equity for all so that global HCV elimination among PWID can be achieved.

  • Browse articles here
  • You can also download the full issue as PDF by creating an account and signing in at the above link

In contrast to Australia’s success with hepatitis C, our response to hepatitis B is lagging

The Conversation, October 15th, 2019

Around one-third of Australians living with hepatitis C have been cured in the last four years. Australia’s response to hepatitis C is seen as a leading example around the world, and the elimination of the disease as a major public health threat is looking like an increasingly achievable goal.

But the situation is much less promising for Australians living with hepatitis B, which is now the most common blood-borne viral infection in Australia. It affects more people than hepatitis C and HIV combined.

Imagining HIV In 2030

Imagining HIV In 2030: Exploring Possible Futures And Charting A Path Forward

ACON, 21/08/2019

What does HIV look like in 2030? How do we make sure people living with HIV age healthily and well? What needs to be done so that everyone benefits equally from NSW’s leading HIV response? These are some of the issues explored in a new discussion paper developed by ACON.

Imagining HIV in 2030 speculates about possible futures over the next decade, examining how current trends and future developments will impact the HIV landscape in NSW. In doing so, it delves into what needs to be done to ensure community, sector and government responses to HIV prevention, treatment and support in NSW remain on course.

Connecting country: busting myths about Indigenous Australians (podcast)

Diversity Council of Australia, 2 Oct 2018

This 20-minute episode doesn’t just feature a beautiful Welcome to Country, but also attempts to connect Country by exploring the cultural and professional gaps that exist for Indigenous Australians at work and asking: where do these issues come from? Why do they persist? And what can we do to finally close the gap?

Helping answer these questions is Linda Burney – the first Aboriginal woman to serve in the House of Representatives, and the first Aboriginal person to serve in the NSW Parliament – as well as Karen Mundine, CEO at Reconciliation Australia.

Researched and hosted by: Andrew Maxwell. Produced and written by: Andrea Maltman Rivera. Executive produced by: Lisa Annese. Contributions from: Catherine Petterson and Simone Empacher Earl. Special thanks to Audiocraft. Welcome to Country by Aunty Norma Ingram.peer

Aboriginal and Torres Strait Islander listeners are warned.  The following podcast may contain voices of deceased people.

HIV and hepatitis pre and post test discussion in Victoria: consultation report

Australian Research Centre in Sex, Health and Society, La Trobe University, Nov 2017

In February 2017, the Australian Research Centre in Sex, Health and Society (ARCSHS) at La Trobe University initiated a consultation which aimed to describe best practice in HIV, hepatitis B and hepatitis C pre and post test discussion in the Victorian context.

Building on existing evidence, and guided by the National Testing Policies, the purpose of this consultation was to better understand the components of a quality testing encounter in the era of elimination, with particular emphasis on the non-medical needs of people around the time of testing and diagnosis.

The focus of this consultation was to identify best practice in pre and post test discussion for HIV, hepatitis B and hepatitis C. A range of health and community providers and researchers discussed the fundamentals of best practice at length, and provided a great many insights into the components of quality testing services.
Importantly, most participants acknowledged that while best practice is a valuable notion, it is not attainable in all health care settings. Best practice, therefore, needs to be flexible enough to be able to fit into any setting where HIV, hepatitis B or hepatitis C testing may occur.

 

People who use drugs require prioritisation not exclusion in efforts to eliminate Hepatitis C

6th International Symposium on Hepatitis Care in Substance Users,  6th Sept 2017

An international conference bringing together hepatitis C experts from around the world is today calling for strategies to prioritise people who use drugs, saying hepatitis C elimination is impossible without them.

“The number of people around the world dying from hepatitis C is increasing. We have the tools to reverse this trend, to eliminate this disease and save millions of lives. But it will not happen until people who use drugs become a focus of our efforts,” said Associate Professor Jason Grebely, President of the International Network of Hepatitis C in Substance Users (INHSU), the convenors of the conference.